PT. Kasa Husada Wira Jatim
Jl. Kalimas barat no 17-19, krembangan utara, surabaya city
Agung wibowo
Phone +62 812 9954 4454
Office +62 31 3526051
Email : info@kasahusada.com
Background :
- East Java total population projection up to 40 million people in 2025
- Total Hospital in East Java are 328 units with 37,379 beds (Indonesia Ministry of Health,2014)
- The ideal infustion fluid ratio is 1 bottle / Population / year. It can be concluded that infusion fluid requirement in East Java is 40 million infusion bottles per year. However, the current ratio was only less half from it supposed.
- There is a gap between supply and demand of national infusion fluid. Only 70% of national infusion fluid demand covered by supplier.
- Many government public Hospital around East Java to be supported.
- Brand Awarness of Kasa Husada in our customers and society.
INFUSION FLUID PLANT BY PT KASA HUSADA WIRA JATIM VIDEO PROFILE
Location:
Desa Glagahsari, Sukorejo – Pasuruan
Project Status :
- Feasibility Study conducted by Surabaya University (UBAYA)
- Geoelectric Stidies has been Conducted on the planned location.
- and claimed to have 3 potential ground water sources with good quality and capacity
- Legal and technical aspect in progress
- f a c i l i t i e s a n d i n f r a s t r u c t u re u n d e r construction
Business Analysis :
- Infusion fluid industry is heavily regulated
- Location selection is taking into account the total productive age population to provide human resources.
- Location selection is taking into account the amount of raw materials available and nieces to distribution channels.
- PT. Kasa Husada Wira Jatim have decades of experiences, in healthcare equipment procurement.
Remarks – Notes
Current Production
| Manufacturer | Volume | Units |
|---|---|---|
| PT Otsuka Indonesia | 18.000.000 | btl/yr |
| PT Widatra Bhakti | 90.000.000 | btl/yr |
| PT B. Braun Indonesia | 20.000.000 | btl/yr |
| PT Sanbe | 10.000.000 | btl/yr |
| PT MJB Pharma | 10.000.000 | btl/yr |
| Total | 148.000.000 | btl/yr |
| 2019 Demand | 250.000.000 | btl/yr |
| Gap | 102.000.000 | btl/yr |
Current Production
| Manufacturer | Volume | Units |
|---|---|---|
| PT Otsuka Indonesia | 18.000.000 | btl/yr |
| PT Widatra Bhakti | 120.000.000 | btl/yr |
| PT B. Braun Indonesia | 50.000.000 | btl/yr |
| PT Sanbe | 10.000.000 | btl/yr |
| PT MJB Pharma | 30.000.000 | btl/yr |
| Total | 228.000.000 | btl/yr |
| 2019 Demand | 250.000.000 | btl/yr |
| Gap | 22.000.000 | btl/yr |
Infusion Fluid Plant Investment Projection
Business Scheme Option :
- Operational Cooperation
Profit sharing between KHWJ/PWU & investor. - Built,Operate & Transfer
KWHJ/PWU invites investor with multi-year
work schemes. - Joint Venture KHWJ/PWU have majority shared (51%)
Timeline Projection :
